Publication | Closed Access
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
549
Citations
15
References
2012
Year
Second-line TreatmentPlacebo-controlled Phase 2OncologyHepatologyMedicinePharmacotherapyLiver CancerAdvanced Hepatocellular CarcinomaCancer TreatmentPharmacologyRadiation OncologyHepatocellular CarcinomaRadiologyHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1